Elanco Animal Health Inc reports results for the quarter ended March 31 - Earnings Summary

Elanco Animal Health Incorporated

07/05/2025 14:32

Elanco Animal Health Inc ELAN.N reported quarterly adjusted earnings of 37 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 34 cents.  The mean expectation of eleven analysts for the quarter was for earnings of 31 cents per share. Wall Street expected results to range from 28 cents to 33 cents per share.

Revenue fell 1% to $1.19 billion from a year ago; analysts expected $1.17 billion.

Elanco Animal Health Inc's reported EPS for the quarter was 13 cents​.

The company reported quarterly net income of $67 million.

Elanco Animal Health Inc shares had fallen by 9.4% this quarter and lost 21.5% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 2.5% in the last three months.​

In the last 30 days, three analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 7 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Elanco Animal Health Inc is $13.00

This summary was machine generated from LSEG data May 7 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
0.31
0.37
Beat
Dec. 31 2024
0.15
0.14
Missed
Sep. 30 2024
0.12
0.13
Beat
Jun. 30 2024
0.24
0.30
Beat